|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Rudy SchreiberPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 2021 ed. Weight: 0.574kg ISBN: 9783030623531ISBN 10: 303062353 Pages: 283 Publication Date: 18 June 2022 Audience: College/higher education , Postgraduate, Research & Scholarly Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationRudy Schreiber got his B.S. in Medicinal Biology and his Ph.D. in Neuropharmacology from the University of Groningen in the Netherlands. He started his career in central nervous system drug discovery in 1993. Subsequently he progressed from bench scientist to senior leadership roles at global pharmaceutical companies, including Servier (France), Bayer (Germany), Roche (CA) and Sepracor (now Sunovion Pharmaceuticals, MA). From 2010 till 2012 he was the SVP of the Neurobiology group of the contract research organization, Evotec (Germany). Rudy’s drug discovery experience covers a wide range of psychiatric and neurologic indications. He also worked with many different classes of molecular targets and led projects ranging from the idea stage throughout proof of principle testing. He has published about 80 papers and 30 patents. In 2012 he founded Suadeo Drug Discovery Consulting LLC in Boston. Rudy joined Maastricht University in 2018 and is the coordinator of the 2-year research masterprogram Drug Development and NeuroHealth. He is a Homo Aquaticus who lives on a boat in Maastricht Marina and spends his free time rowing on the Maas river or sailing offshore. Tab Content 6Author Website:Countries AvailableAll regions |